Christopher Slatore, MD
Cross-Appointed Research Faculty
Dr. Slatore is a Pulmonary/Critical Care physician and a Core Investigator at the VA Portland Health Care System's Center for Involving Veterans in Care. He received medical and master of epidemiology degrees from the University of Washington (UW). He completed his residency in internal medicine and fellowship in pulmonary & critical care medicine at the UW as well.He is an Associate Professor of Medicine in the Division of Pulmonary & Critical Care Medicine and Adjunct Associate Research Professor in the Department of Radiation Medicine at Oregon Health & Science University, Medical Director of the Unsuspected Radiologic Findings system, and Co-Leader for the Lung Cancer Screening Clinical Demonstration Project at the VAPORHCS. Dr. Slatore has published over 30 peer-reviewed manuscripts. He is interested in the prevention, detection, treatment, and healthcare delivery for patients with tobacco-related lung diseases, chiefly lung cancer and chronic obstructive pulmonary disease (COPD). Dr. Slatore’s research has focused on improving patient outcomes and identifying innovative approaches to treatment in these areas.
As the recipient of a VA HSR&D Career Development Award, he investigated the influence of patient-clinician communication on patient-centered outcomes for those undergoing the lung cancer evaluation process. He is also the principal investigator for an American Cancer Society funded research study to evaluate patient-centered outcomes for individuals offered lung cancer screening. He was recently awarded a grant from the Radiation Oncology Institute to evaluate patient-centered outcomes and communication processes among patients with early stage lung cancer who are considering curative radiation or surgical therapies. Through the application of comparative research methodologies, Dr. Slatore’s goal is to improve healthcare quality for people with tobacco-related lung diseases.
Articles and Citations
qualitative study of clinicians caring for patients with early stage non-small
cell lung cancer
- Drs. Slatore (PI) &Thomas, Jr. (Co-PI) presented on behalf of the Early Stage Lung Cancer